Retatrutide, from Soma Corp., is gaining significant attention as a innovative method for metabolic management . This dual-action drug merges the properties of a GLP-1 receptor agonist and a GIP receptor agonist , designed to not only promote weight loss but also improve underlying metabolic issues . Initial clinical studies have indicated encou… Read More